Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 30, 1231-1235, May 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, T.-J.
Right arrow Articles by Vas, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, T.-J.
Right arrow Articles by Vas, S. I.

Effects of Antibodies on L5178Y Mouse Leukemia Cells Cultured in Vitro1

T.-J. Yang2 and S. I. Vas

Department of Microbiology and Immunology, McGill University, Montreal 110, Quebec, Canada

An in vitro system with the use of a rabbit serum medium-adapted subline of L5178Y cells and rabbit antisera was used in the present study.

Heat-inactivated antisera inhibited both uptake and incorporation of glycine-2-14C into cell protein and killed the cells. These effects became demonstrable only after 6 hr and reached a maximum after 24 to 48 hr. Total cell counts decreased even more slowly and the initial cause of cell death did not seem to result from cell lysis.

Sodium succinate partially protected the cells against killing or inhibition by antisera. Viable cell counts, uptake, and incorporation of glycine-2-14C increased greatly. Malonate reversed completely the action of succinate. Apparently, the energy derived from the oxidation of succinate is sufficient for many cells to grow and incorporate the amino acid into cell protein. Glucose and nicotinamide also showed similar protective effects.

Antiserum was observed to have a transient stimulatory effect on viable cell counts, uptake, and incorporation of glycine-2-14C at about 2 hr after the addition of antisera. Whether this is due to stimulation of noncycling G2 cells by antiserum is currently under study.

During the entire experimental period, i.e., up to 4 days, a small portion of the cell population remained viable. Many of these looked much larger and the incorporation rate, but not uptake rate, of glycine-2-14C/106 viable cells was much higher than that of the controls. Addition of succinate increased the rate still further. Cultures treated with antiserum recovered if fresh medium without antisera was added at 24 to 48 hr.

Possible modes of action of the antisera were discussed.

1 This investigation was supported by a grant from the Medical Research Council of Canada.

2 Holder of a Medical Research Council studentship.

Received 9/ 8/69. Accepted 10/30/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1970 by the American Association for Cancer Research.